[HTML][HTML] The efficacy and safety of metastasis-directed therapy in patients with prostate cancer: a systematic review and meta-analysis of prospective studies
Context Despite the lack of level 1 evidence, metastasis-directed therapy (MDT) is used
widely in the management of metastatic prostate cancer (mPCa) patients. Data are …
widely in the management of metastatic prostate cancer (mPCa) patients. Data are …
Metastatic prostate cancer: treatment options
Abstract Background: Metastatic prostate cancer (PCa) is associated with considerable
diminished overall survival (OS). Standard treatment for metastatic PCa has long been …
diminished overall survival (OS). Standard treatment for metastatic PCa has long been …
Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis
Importance The oligometastatic paradigm postulates that patients with a limited number of
metastases can be treated with ablative local therapy to each site of disease with curative …
metastases can be treated with ablative local therapy to each site of disease with curative …
Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature
Context The introduction of novel imaging modalities has increased the detection of
oligometastatic prostate cancer (PCa) recurrence, potentially justifying the use of a …
oligometastatic prostate cancer (PCa) recurrence, potentially justifying the use of a …
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations
The oligometastatic state has been proposed as an intermediate stage of cancer spread
between localized disease and widespread metastases. With improvements in diagnostic …
between localized disease and widespread metastases. With improvements in diagnostic …
[HTML][HTML] The biology and treatment of oligometastatic cancer
DK Reyes, KJ Pienta - Oncotarget, 2015 - ncbi.nlm.nih.gov
Clinical reports of limited and treatable cancer metastases, a disease state that exists in a
transitional zone between localized and widespread systemic disease, were noted on …
transitional zone between localized and widespread systemic disease, were noted on …
Prostate cancer treatment–China's perspective
J Liu, L Dong, Y Zhu, B Dong, J Sha, HH Zhu, J Pan… - Cancer letters, 2022 - Elsevier
Prostate cancer (PCa) incidence and mortality have rapidly increased in China. Notably,
unique epidemiological characteristics of PCa are found in the Chinese PCa population …
unique epidemiological characteristics of PCa are found in the Chinese PCa population …
Progression-free survival following stereotactic body radiotherapy for oligometastatic prostate cancer treatment-naive recurrence: a multi-institutional analysis
The literature on metastasis-directed therapy for oligometastatic prostate cancer (PCa)
recurrence consists of small heterogeneous studies. This study aimed to reduce the …
recurrence consists of small heterogeneous studies. This study aimed to reduce the …
Radiotherapy for renal-cell carcinoma
G De Meerleer, V Khoo, B Escudier, S Joniau… - The Lancet …, 2014 - thelancet.com
Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be
wrong. If given in a few (even single) fractions, but at a high fraction dose, stereotactic body …
wrong. If given in a few (even single) fractions, but at a high fraction dose, stereotactic body …
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
K Decaestecker, G De Meerleer, B Lambert, L Delrue… - Radiation …, 2014 - Springer
Purpose To assess the outcome of prostate cancer (PCa) patients diagnosed with
oligometastatic disease at recurrence and treated with stereotactic body radiotherapy …
oligometastatic disease at recurrence and treated with stereotactic body radiotherapy …